Insights from Bayer’s $1.5 Billion VC Fund | Lucio Iannone, Head of Health Venture Investments (VP) at Leaps by Bayer
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
How Leaps Evaluates Scientific Validity
Jess asks who Lucio consults on science; Lucio describes internal reviews, clinician and preclinical experts, and KOL interviews to vet translational risk.
Transcript
Play full episode
